Efficacy and safety of first-line bosutinib versus imatinib in the BFORE trial: 18-month follow-up Meeting Abstract


Authors: Clark, R. E.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Dyagil, I.; Glushko, N.; Milojkovic, D.; Le Coutre, P.; Garcia-Gutierrez, V.; Crescenzo, R.; Leip, E.; Bardy-Bouxin, N.; Hochhaus, A.; Bruemmendorf, T. H.; Cortes, J. E.; The BFORE investigators
Abstract Title: Efficacy and safety of first-line bosutinib versus imatinib in the BFORE trial: 18-month follow-up
Meeting Title: 58th Annual Scientific Meeting of the British Society for Haematology
Keywords: clinical trial; bosutinib; chronic myeloid leukaemia
Journal Title: British Journal of Haematology
Volume: 181
Issue: Suppl. 1
Meeting Dates: 2018 Apr 16-18
Meeting Location: Liverpool, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2018-04-01
Start Page: 7
End Page: 8
Language: English
ACCESSION: WOS:000430117900005
PROVIDER: wos
PUBMED: 29658101
DOI: 10.1111/bjh.15226
Notes: Meeting Abstract: BSH18-OR-004 -- 58th Annual Scientific Meeting of the British-Society-for-Haematology -- APR 16-18, 2018 -- Liverpool, ENGLAND -- 1 -- SI -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    267 Mauro